Addressing Cancer Disparities in the Hispanic Population in the US and LMICs
Adrian P Hunis*
Medical Oncologist, Professor of Internal Medicine (UBA), Professor of Oncology (UMAI), Emeritus Member of ASCO, Emeritus Member of ESMO, Argentina
*Corresponding Author: Adrian P Hunis, Medical Oncologist, Professor of Internal Medicine (UBA), Professor of Oncology (UMAI), Emeritus Member of ASCO, Emeritus Member of ESMO, Argentina.
July 10, 2023; Published: July 25, 2023
This discussion focuses on addressing cancer disparities in the Hispanic population in the United States and middle- and low-income populations globally. It emphasizes the importance of access to determinations, molecular panels, genetic studies, new therapeutic modalities, diagnostic methods, palliative therapies, and good medicine. Strategies such as increasing awareness and education, improving healthcare access, providing culturally competent care, promoting research and data collection, fostering collaboration and partnerships, addressing socioeconomic factors, and supporting global initiatives are discussed. The goal is to achieve equitable healthcare outcomes and reduce cancer disparities through a comprehensive and multidimensional approach .
Keywords: Cancer; Healthcare; United States
- Smedley BD., et al. “Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care”. National Academies Press; (2003).
- Rodriguez MA., et al. “Perceived quality of care, receipt of preventive care, and usual source of health care among undocumented and other Latinos”. Journal of General Internal Medicine 24 (2009): 508-513.
- Pinheiro PS., et al. “High Cancer Mortality for US-born Latinos: Evidence from California and Texas”. BMC Cancer1 (2017): 478.
- Martinez Tyson D., et al. “Cancer prevention and screening practices among Latinos in Washington State: a statewide cross-sectional analysis”. BMC Public Health1 (2017): 339.
- Krok-Schoen JL., et al. “Factors associated with rural-urban disparities in colorectal cancer screening in the United States: A systematic review and meta-analysis”. Cancer Epidemiology, Biomarkers and Prevention7 (2017): 992-1002.
- Gany FM., et al. “Cancer screening among Latino subgroups in the United States”. Preventive Medicine 5 (2006): 429-435.
- Maly RC., et al. “Impact of culture and language on cancer care for older patients”. Journal of the National Cancer Institute Monographs48 (2014): 81-87.
- Meade CD., et al. “Impact of a multimedia intervention on HPV knowledge and vaccine acceptance among Latina adolescents”. Journal of Cancer Education1 (2015): 152-157.
- Casillas J., et al. ““If we build it, will they come?”: A qualitative evaluation of healthcare provider perspectives on telemedicine for acute trauma care in the U.S.-Mexico border region”. Telemedicine and e-Health5 (2017): 431-440.
- Lopez ED., et al. “Men’s perspectives on factors that influence the adoption of telemedicine for prostate cancer care”. American Journal of Men’s Health6 (2017): 1777-1788.
- Ramirez AG., et al. “Mexican American collaborative: a cultural, community-based research initiative”. Ethnicity and Disease 14 (2004): S3-8.
- Kagawa-Singer M., et al. “Cancer, culture, and health disparities: Time to chart a new course?” CA: A Cancer Journal for Clinicians1 (2010): 12-39.
- Byrd TL., et al. “Barriers and facilitators of cervical cancer screening among Hispanic women”. Ethnicity and Disease1 (2007): 129-134.
- Owusu D., et al. “Barriers and facilitators to mammography adherence in underserved women: A qualitative analysis”. Women’s Health Issues4 (2018): 351-357.
- Ramirez AG., et al. “Promoting cancer research and diversity through the NCI-funded Special Populations Networks”. Journal of Cancer Education4 (2011): 649-655.
- Chalela P., et al. “HIV-related stigma, social support, and psychological distress among individuals initiating ART in Honduras”. PLoS ONE10 (2018): e0206616.
- Shah MA., et al. “Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy specimens”. Journal of Virology2 (2009): 750-759.
- Lee JS., et al. “Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to neuroblastoma therapy (NANT) trial”. Journal of Clinical Oncology15 (2012): 1699-1706.
- O’Neill SC., et al. “Incidence and patient survival of central nervous system cancers in the United States, 2006-2015”. Frontiers in Public Health 7 (2019): 319.
- Simonetto C., et al. “Evaluation of high-dose chemotherapy with autologous stem cell transplantation, as consolidation therapy in patients with triple-negative breast cancer”. Breast Cancer Research and Treatment2 (2019): 367-374.